{"entity":{"id":"elpiscience-suzhou-biopharma","kind":"company","name":"Elpiscience (Suzhou) Biopharma","aka":["Elpiscience (Suzhou) Biopharma, Ltd.","Elpiscience Biopharma, Ltd."],"tldr":"Elpiscience (Suzhou) Biopharma is a China-based biotechnology company running 2 late-stage cancer trials of ES014 and ES102 in desmoid tumour and non-small-cell lung cancer.","summary":"Elpiscience (Suzhou) Biopharma, based in Suzhou, China, is a biotechnology company. Elpiscience is a biopharmaceutical company developing immunotherapies for oncology and autoimmune disease. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials, testing ES014 and ES102 in desmoid tumour and non-small-cell lung cancer. The largest, NCT07541430 (A Study in Adults With Desmoid Tumours), plans to enrol 50 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.","asOf":"2026-09-11","links":[{"label":"Official website","url":"https://www.elpiscience.com"},{"label":"ClinicalTrials.gov: trials led by Elpiscience (Suzhou) Biopharma","url":"https://clinicaltrials.gov/search?lead=Elpiscience%20(Suzhou)%20Biopharma%2C%20Ltd."}],"tags":["ctgov-sponsor"],"related":[],"cancers":["desmoid-tumour","nsclc"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["nct07541430","nct06623136"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Suzhou","country":"CN","companyType":"biotech","website":"https://www.elpiscience.com","investors":[],"funding":[]},"route":"/companies/elpiscience-suzhou-biopharma/","neighbours":{"cancer":[{"id":"desmoid-tumour","kind":"cancer","name":"Desmoid tumour","route":"/cancers/desmoid-tumour/"},{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"}],"trial":[{"id":"nct07541430","kind":"trial","name":"A Study in Adults With Desmoid Tumors","route":"/trials/nct07541430/"},{"id":"nct06623136","kind":"trial","name":"A Study of ES102 in Combination With Toripalimab in Subjects With Advanced Non-small Cell Lung Cancer","route":"/trials/nct06623136/"}]}}